1. Home
  2. AFMD vs PLBY Comparison

AFMD vs PLBY Comparison

Compare AFMD & PLBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFMD
  • PLBY
  • Stock Information
  • Founded
  • AFMD 2000
  • PLBY 1953
  • Country
  • AFMD Germany
  • PLBY United States
  • Employees
  • AFMD N/A
  • PLBY N/A
  • Industry
  • AFMD Biotechnology: Pharmaceutical Preparations
  • PLBY Recreational Games/Products/Toys
  • Sector
  • AFMD Health Care
  • PLBY Consumer Discretionary
  • Exchange
  • AFMD Nasdaq
  • PLBY Nasdaq
  • Market Cap
  • AFMD 55.6M
  • PLBY 53.2M
  • IPO Year
  • AFMD 2014
  • PLBY N/A
  • Fundamental
  • Price
  • AFMD $3.65
  • PLBY $1.11
  • Analyst Decision
  • AFMD Strong Buy
  • PLBY Buy
  • Analyst Count
  • AFMD 5
  • PLBY 2
  • Target Price
  • AFMD $16.25
  • PLBY $2.35
  • AVG Volume (30 Days)
  • AFMD 98.0K
  • PLBY 8.4M
  • Earning Date
  • AFMD 11-14-2024
  • PLBY 11-12-2024
  • Dividend Yield
  • AFMD N/A
  • PLBY N/A
  • EPS Growth
  • AFMD N/A
  • PLBY N/A
  • EPS
  • AFMD N/A
  • PLBY N/A
  • Revenue
  • AFMD $7,959,927.00
  • PLBY $72,188,000.00
  • Revenue This Year
  • AFMD N/A
  • PLBY N/A
  • Revenue Next Year
  • AFMD $48.98
  • PLBY N/A
  • P/E Ratio
  • AFMD N/A
  • PLBY N/A
  • Revenue Growth
  • AFMD N/A
  • PLBY N/A
  • 52 Week Low
  • AFMD $2.92
  • PLBY $0.44
  • 52 Week High
  • AFMD $8.95
  • PLBY $1.55
  • Technical
  • Relative Strength Index (RSI)
  • AFMD 55.19
  • PLBY 54.66
  • Support Level
  • AFMD $3.63
  • PLBY $0.85
  • Resistance Level
  • AFMD $3.98
  • PLBY $1.14
  • Average True Range (ATR)
  • AFMD 0.24
  • PLBY 0.18
  • MACD
  • AFMD 0.04
  • PLBY -0.01
  • Stochastic Oscillator
  • AFMD 55.65
  • PLBY 38.24

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

About PLBY PLBY Group Inc.

PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.

Share on Social Networks: